Table 1.
Anti-CENP-P (+) | Anti-CENP-Q (+) | ||
---|---|---|---|
Cohort | Cases | No. (%, p value) | No. (%, p value) |
SSc | |||
ACA+ | 35 | 14 (40) | 11 (31.4) |
ACA‒ | 151 | 9 (6, < 0.0001) | 0 (0, < 0.0001) |
pSS (ACA+) | 18 | 1 (5.6, 0.0207) | 2 (11.1, 0.1771) |
SLE (ACA+) | 20 | 3 (15, 0.1038) | 5 (25, 0.7608) |
RA (ACA+) | 13 | 2 (15.4, 0.1703) | 0 (0, 0.0228) |
PBC (ACA+) | 18 | 5 (27.8, 0.5644) | 1 (5.6, 0.0412) |
Healthy (ACA‒) | 31 | 0 (0, 0.0002) | 0 (0, 0.0020) |
SLE: systemic lupus erythematosus; pSS: primary Sjögren syndrome; RA: rheumatoid arthritis; PBC: primary biliary cirrhosis.